Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection

BMC Infectious Diseases

Table 2 Comparison of vital status by admission status, number of diseases at admission, and treatment in a sample of MERS-CoV patients (n = 63)

Admission Status	N	Vital Status		P-value
Admission Status	N	Alive N (%)	Dead N (%)	P-value
Pneumonia / ARDS^a	55	45 (95.7)	10 (62.5)	<0.0001
Septic Shock / MOF^b	7	1 (2.1)	6 (37.5)
Abdominal pain and diarrhoea	1	1 (2.1)	0 (0.0)
N. of diseases at admission^c
No chronic disease	24	18 (38.3)	6 (37.5)	0.131
One chronic disease	9	9 (19.1)	0 (0.0)
Two or more diseases	30	20 (42.6)	10 (62.5)
Management
Took the regimen^d	61	47 (100.0)	14 (87.5)	0.014
Did not take the regimen	2	0 (0.0)	2 (12.5)	0.014

^aARDS: Acute respiratory distress syndrome
^bMOF: Multiple organ failure
^cChronic diseases included diabetes, hypertension, hepatitis C, chronic renal diseases, and chronic heart diseases
^dAll regimens included the combination therapy of Interferon alpha and Ribavirin

ISSN: 1471-2334